Leadership Overview
PTC Therapeutics has 4 executives leading key functions including clinical development, information technology, commercial operations, and strategic staff management.
Focused on advancing small molecule drug discovery, PTC Therapeutics maintains a commitment to addressing rare disorders through innovative post-transcriptional control processes and global commercial expansion.
Focused on advancing small molecule drug discovery, PTC Therapeutics maintains a commitment to addressing rare disorders through innovative post-transcriptional control processes and global commercial expansion.
Leadership Roles at PTC Therapeutics
Quintus Ngumah - Vice President, Clinical Development & Chief Marketing Officer, Cos To The
Quintus Ngumah, the Vice President, Clinical Development & Chief Marketing Officer, Cos To The at PTC Therapeutics, directs the advancement of small molecule drug pipelines. Overseeing clinical trial protocols, the Vice President, Clinical Development & Chief Marketing Officer, Cos To The ensures rigorous data collection for nonsense mutation Duchenne muscular dystrophy treatments. This leadership role involves coordinating with regulatory bodies to accelerate market access for Translarna. By aligning clinical milestones with commercial launch strategies, Quintus Ngumah optimizes the therapeutic impact of the company portfolio. The Vice President, Clinical Development & Chief Marketing Officer, Cos To The manages cross-functional teams to bridge the gap between laboratory discovery and patient-facing solutions. Through strategic oversight of global clinical development programs, the executive drives the biopharmaceutical mission forward, ensuring that scientific breakthroughs translate into tangible health outcomes for patients requiring specialized care across international markets.
Linda Montella-Carter - Chief Information Officer & Senior VP
Linda Montella-Carter, the Chief Information Officer & Senior VP at PTC Therapeutics, architects the digital infrastructure supporting biopharmaceutical research and development. Managing enterprise-wide data security, the Chief Information Officer & Senior VP ensures the integrity of post-transcriptional control research databases. This leadership role involves integrating advanced analytics to streamline drug discovery workflows and improve operational efficiency. By modernizing internal systems, Linda Montella-Carter facilitates seamless collaboration between research laboratories and commercial departments. The Chief Information Officer & Senior VP oversees the implementation of scalable cloud solutions that support the company's global footprint. Through the deployment of robust information technology frameworks, the executive secures the intellectual property and operational data necessary for maintaining a competitive edge in the pharmaceutical industry. The Chief Information Officer & Senior VP drives digital transformation initiatives that empower the entire organization to achieve faster development cycles and superior patient outcomes.

Daphny Massingale - Senior Director, Chief of Staff and Commercial Operations- North America
Daphny Massingale, the Senior Director, Chief of Staff and Commercial Operations- North America at PTC Therapeutics, manages the strategic execution of commercial initiatives across the North American market. Overseeing the alignment of sales force activities with corporate objectives, the Senior Director, Chief of Staff and Commercial Operations- North America ensures the effective distribution of Translarna to ambulatory patients. This leadership role involves coordinating executive priorities and streamlining internal communication to enhance organizational agility. By analyzing regional market trends, Daphny Massingale optimizes commercial performance and resource allocation. The Senior Director, Chief of Staff and Commercial Operations- North America facilitates cross-departmental projects that support the company's growth trajectory. Through rigorous operational oversight, the executive drives the implementation of patient-centric commercial strategies. The Senior Director, Chief of Staff and Commercial Operations- North America maintains high standards of operational excellence, ensuring that the company's therapeutic solutions reach target populations efficiently while supporting long-term business sustainability.
Meghan Schwarzenbek - Chief of Staff To the Chief Information Officer
Meghan Schwarzenbek, the Chief of Staff To the Chief Information Officer at PTC Therapeutics, coordinates the strategic initiatives and administrative functions within the information technology division. Overseeing the prioritization of IT projects, the Chief of Staff To the Chief Information Officer ensures that technical resources align with the company's drug development goals. This leadership role involves managing the flow of information between the CIO and other executive leaders to facilitate rapid decision-making. By streamlining internal processes, Meghan Schwarzenbek enhances the productivity of the technology team. The Chief of Staff To the Chief Information Officer monitors the progress of digital infrastructure upgrades that support the company's research capabilities. Through effective project management and stakeholder engagement, the executive drives the successful execution of the IT roadmap. The Chief of Staff To the Chief Information Officer ensures that the technology department remains focused on delivering high-impact solutions that support the broader biopharmaceutical mission and operational requirements.
Explore Leadership Teams in Manufacturing
Cipla Limited is a global pharmaceutical company based in Mumbai, India, with operations in India, the United States, South Africa, and other international markets. Through its Pharmaceuticals and New Ventures segments, the company develops, manufactures, markets, and distributes a broad range of generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and finished formulations. Its products address multiple therapeutic areas, including cardiovascular disease, pulmonary and kidney conditions, neurological and psychiatric disorders, HIV/AIDS, respiratory and asthma care, oncology, diabetes and metabolic disorders, infectious diseases, critical care, women’s health, ophthalmology, and child health. In addition to its core pharmaceutical portfolio, Cipla is active in consumer healthcare, biosimilars, and specialty medicine businesses. Founded in 1935, Cipla has grown into a major global healthcare player.
Company Leadership MF
KI
LB
Founded in 2003, Phibro Animal Health Corporation is a global manufacturer and marketer of animal health pharmaceuticals, animal nutrition, and performance products. The company is headquartered in Teaneck, New Jersey.
Company Leadership
LM
MG
LV
PharmaLogic Holdings Corp. is a global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. Through a network of radiopharmacies and manufacturing facilities across North America and Europe, it develops, manufactures, and distributes clinical and commercial radiopharmaceutical products to pharmaceutical partners and healthcare providers.
Company Leadership
HP
GP
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership YS
AH
YB